Literature DB >> 1922572

Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma.

J Borovanský1, P Mirejovský, P A Riley.   

Abstract

Melanogenesis has been regarded as a hazard for pigment cells which are endangered by reactive quinones and semiquinones generated by this process. Normally the potentially cytotoxic species are confined to melanosomes by a limiting membrane and thus separated from the rest of the cell. Our electron microscopic investigation has demonstrated the presence of abnormal and incomplete melanosomes in human melanomas from epidermal and mucosal sites, in melanoma metastases, and in B16 mouse melanoma. We conclude that significant leakage of reactive melanin precursors including free radical species may occur from aberrant melanosomes in pigmented tumors. This would be expected to be reflected by fully extended physiological scavenging mechanisms, and by local and distant manifestations of cytotoxicity: Among these manifestations is free radical damage to the liver, detected by a thiobarbituric acid-reactive substances assay, in B16 melanoma-bearing mice. The efflux of toxic species from abnormal melanosomes may explain both the observed frequent occurrence of necrosis in melanomas and the therapeutic efficacy of tyrosinase substrates and may also be one of the factors influencing the extent of melanogenuria.

Entities:  

Mesh:

Year:  1991        PMID: 1922572

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  9 in total

Review 1.  Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis.

Authors:  Ryan W Dellinger; Feng Liu-Smith; Frank L Meyskens
Journal:  J Photochem Photobiol B       Date:  2014-06-20       Impact factor: 6.252

2.  Classical autophagy proteins LC3B and ATG4B facilitate melanosome movement on cytoskeletal tracks.

Authors:  Amrita Ramkumar; Divya Murthy; Desingu Ayyappa Raja; Archana Singh; Anusha Krishnan; Sangeeta Khanna; Archana Vats; Lipi Thukral; Pushkar Sharma; Sridhar Sivasubbu; Rajni Rani; Vivek T Natarajan; Rajesh S Gokhale
Journal:  Autophagy       Date:  2017-06-09       Impact factor: 16.016

3.  Amyloids, melanins and oxidative stress in melanomagenesis.

Authors:  Feng Liu-Smith; Carrie Poe; Patrick J Farmer; Frank L Meyskens
Journal:  Exp Dermatol       Date:  2014-11-18       Impact factor: 3.960

4.  Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage.

Authors:  F A Offner; J Schiefer; H C Wirtz; I Bigalke; M Pavelka; G Hollweg; C Ensinger; B Klosterhalfen; C Mittermayer; C J Kirkpatrick
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

5.  The effect of L-DOPA on Cryptococcus neoformans growth and gene expression.

Authors:  Helene C Eisenman; Siu-Kei Chow; Kenneth K Tsé; Erin E McClelland; Arturo Casadevall
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

6.  Melanosomal damage in normal human melanocytes induced by UVB and metal uptake--a basis for the pro-oxidant state of melanoma.

Authors:  Shirley Gidanian; Mallory Mentelle; Frank L Meyskens; Patrick J Farmer
Journal:  Photochem Photobiol       Date:  2008-03-07       Impact factor: 3.421

7.  Unraveling the molecular nature of melanin changes in metastatic cancer.

Authors:  Kuk-Youn Ju; Simone Degan; Martin C Fischer; Kevin C Zhou; Xiaomeng Jia; Jin Yu; Warren S Warren
Journal:  J Biomed Opt       Date:  2019-04       Impact factor: 3.170

Review 8.  Significance of 5-S-Cysteinyldopa as a Marker for Melanoma.

Authors:  Kazumasa Wakamatsu; Satoshi Fukushima; Akane Minagawa; Toshikazu Omodaka; Tokimasa Hida; Naohito Hatta; Minoru Takata; Hisashi Uhara; Ryuhei Okuyama; Hironobu Ihn
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

9.  Nano-scale morphology of melanosomes revealed by small-angle X-ray scattering.

Authors:  Thomas Gorniak; Tamas Haraszti; Vasyl M Garamus; Andreas R Buck; Tobias Senkbeil; Marius Priebe; Adam Hedberg-Buenz; Demelza Koehn; Tim Salditt; Michael Grunze; Michael G Anderson; Axel Rosenhahn
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.